387 related articles for article (PubMed ID: 12570331)
1. Chemoprevention strategies for prostate cancer.
Bosland MC; McCormick DL; Melamed J; Walden PD; Zeleniuch-Jacquotte A; Lumey LH
Eur J Cancer Prev; 2002 Aug; 11 Suppl 2():S18-27. PubMed ID: 12570331
[TBL] [Abstract][Full Text] [Related]
2. Significance of chemoprevention for prostate cancer development: experimental in vivo approaches to chemoprevention.
Shirai T
Pathol Int; 2008 Jan; 58(1):1-16. PubMed ID: 18067635
[TBL] [Abstract][Full Text] [Related]
3. Progress in cancer chemoprevention: perspectives on agent selection and short-term clinical intervention trials.
Kelloff GJ; Boone CW; Steele VE; Crowell JA; Lubet R; Sigman CC
Cancer Res; 1994 Apr; 54(7 Suppl):2015s-2024s. PubMed ID: 8137331
[TBL] [Abstract][Full Text] [Related]
4. Prostate cancer chemoprevention: current status and future prospects.
Gupta S
Toxicol Appl Pharmacol; 2007 Nov; 224(3):369-76. PubMed ID: 17189645
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological approaches to reducing the risk of prostate cancer.
Rittmaster RS; Fleshner NE; Thompson IM
Eur Urol; 2009 May; 55(5):1064-73. PubMed ID: 19200641
[TBL] [Abstract][Full Text] [Related]
6. Chemoprevention of prostate cancer.
Brand TC; Canby-Hagino ED; Pratap Kumar A; Ghosh R; Leach RJ; Thompson IM
Hematol Oncol Clin North Am; 2006 Aug; 20(4):831-43. PubMed ID: 16861117
[TBL] [Abstract][Full Text] [Related]
7. Current and future status of prostate cancer chemoprevention.
Fujimoto N; Nomura M; Matsumoto T
Expert Rev Anticancer Ther; 2006 Jan; 6(1):59-71. PubMed ID: 16375645
[TBL] [Abstract][Full Text] [Related]
8. The cost of prostate cancer chemoprevention: a decision analysis model.
Svatek RS; Lee JJ; Roehrborn CG; Lippman SM; Lotan Y
Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1485-9. PubMed ID: 16896037
[TBL] [Abstract][Full Text] [Related]
9. Can we prevent prostate cancer? Rationale and current status of prostate cancer chemoprevention.
Fujimoto N; Chang C; Nomura M; Matsumoto T
Urol Int; 2005; 74(4):289-97. PubMed ID: 15897691
[TBL] [Abstract][Full Text] [Related]
10. The use of PSA as biomarker in nutritional intervention studies of prostate cancer.
van Weerden WM; Schröder FH
Chem Biol Interact; 2008 Jan; 171(2):204-11. PubMed ID: 18177847
[TBL] [Abstract][Full Text] [Related]
11. Tea beverage in chemoprevention and chemotherapy of prostate cancer.
Siddiqui IA; Saleem M; Adhami VM; Asim M; Mukhtar H
Acta Pharmacol Sin; 2007 Sep; 28(9):1392-408. PubMed ID: 17723173
[TBL] [Abstract][Full Text] [Related]
12. Prostate cancer and prostate-specific antigen (PSA) screening in Austria.
Vutuc C; Schernhammer ES; Haidinger G; Waldhör T
Wien Klin Wochenschr; 2005 Jul; 117(13-14):457-61. PubMed ID: 16091872
[TBL] [Abstract][Full Text] [Related]
13. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
14. Tea beverage in chemoprevention of prostate cancer: a mini-review.
Saleem M; Adhami VM; Siddiqui IA; Mukhtar H
Nutr Cancer; 2003; 47(1):13-23. PubMed ID: 14769533
[TBL] [Abstract][Full Text] [Related]
15. Update on prostate cancer chemoprevention.
Lowe JF; Frazee LA
Pharmacotherapy; 2006 Mar; 26(3):353-9. PubMed ID: 16503715
[TBL] [Abstract][Full Text] [Related]
16. Target populations and strategies for chemoprevention trials of prostate cancer.
Bostwick DG
J Cell Biochem Suppl; 1994; 19():191-6. PubMed ID: 7823591
[TBL] [Abstract][Full Text] [Related]
17. [Nutrition and pharmacological treatment for prevention of prostate cancer].
Segev Y; Nativ O
Harefuah; 2006 Jan; 145(1):47-51, 76-7. PubMed ID: 16450727
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of prostate cancer.
Thompson IM; Tangen CM; Goodman PJ; Lucia MS; Klein EA
J Urol; 2009 Aug; 182(2):499-507; discussion 508. PubMed ID: 19524966
[TBL] [Abstract][Full Text] [Related]
19. Prevention of hormone-related cancers: prostate cancer.
Parnes HL; Thompson IM; Ford LG
J Clin Oncol; 2005 Jan; 23(2):368-77. PubMed ID: 15637399
[TBL] [Abstract][Full Text] [Related]
20. Chemoprevention of prostate cancer through dietary agents: progress and promise.
Syed DN; Khan N; Afaq F; Mukhtar H
Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2193-203. PubMed ID: 18006906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]